Treace Medical Concepts, Inc. (TMCI)
NASDAQ: TMCI · Real-Time Price · USD
6.09
+0.07 (1.16%)
At close: Jul 2, 2025, 4:00 PM
5.84
-0.25 (-4.11%)
After-hours: Jul 2, 2025, 5:35 PM EDT

Treace Medical Concepts Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2019
Period Ending
Jul '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2019
3834637861,276991-
Upgrade
Market Cap Growth
-35.08%-41.06%-38.37%28.74%--
Upgrade
Enterprise Value
3764517351,259911-
Upgrade
Last Close Price
6.097.4412.7522.9918.64-
Upgrade
PS Ratio
1.802.214.209.0010.50-
Upgrade
PB Ratio
3.644.115.7021.0810.65-
Upgrade
P/TBV Ratio
4.525.046.7721.0810.65-
Upgrade
EV/Sales Ratio
1.792.153.938.889.65-
Upgrade
Debt / Equity Ratio
0.660.620.511.130.3240.24
Upgrade
Debt / EBITDA Ratio
-----15.12
Upgrade
Asset Turnover
0.940.890.910.951.031.60
Upgrade
Inventory Turnover
1.131.201.451.711.841.86
Upgrade
Quick Ratio
3.253.353.613.676.832.81
Upgrade
Current Ratio
4.504.624.414.417.583.53
Upgrade
Return on Equity (ROE)
-45.73%-44.45%-49.91%-55.75%-43.80%-186.34%
Upgrade
Return on Assets (ROA)
-14.56%-14.83%-15.64%-14.53%-11.30%1.49%
Upgrade
Return on Capital (ROIC)
-17.59%-17.80%-19.05%-17.30%-13.35%1.97%
Upgrade
Return on Capital Employed (ROCE)
-----2.80%
Upgrade
Earnings Yield
-13.83%-12.03%-6.30%-3.36%-2.07%-
Upgrade
FCF Yield
-9.65%-10.52%-5.85%-3.56%-2.01%-
Upgrade
Buyback Yield / Dilution
-1.15%-2.07%-10.09%-14.17%-30.61%-0.43%
Upgrade
Updated Feb 27, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q